https://www.ajmc.com/view/low-hepatitis-b-reactivation-risk-in-patients-treated-with-immune-checkpoint-inhibitors-study-says
0
0
9/29/23 at 2:00pm
Organization
Ajmc.com
Author
Brooke McCormick
41 words
0
Comments
The researchers found that patients with cancer exposed to immune checkpoint inhibitors have a 1.3% risk of hepatitis B virus reactivation.
You are the first to view
Create an account
or login to join the discussion